ScholarWorks@Hanyang University

2. Conference Papers(서울 의과대학 > 서울 내과학교실 > 2. Conference Papers)7,639

Browse
rss_1.0 rss_2.0 atom_1.0

Subscribe to this collection to receive daily e-mail notification of new additions

Collection's Items (Sorted by Submit Date in Descending order): 5001 to 5020 of 7639

Tomosynthesis As a New Diagnostic Tool For Evaluation Of Ankylosing Spondylitis With Modified Stoke Ankylosing Spondylitis Spinal Score: A Comparison With Plain Radiographs

김태환

ConferenceIssue Date2013Placesan diego
Follow-Up Testing Of Interferon-Gamma Release Assays For The Diagnosis Of Hidden Tuberculosis Infection In Patients Receiving Tumor Necrosis Factor Alpha Antagonists

김태환

ConferenceIssue Date2013Placesan diego
Is Isoniazid Treatment For LTBI Safe For RA Patients With TNF Inhibitor Therapy?

김태환

ConferenceIssue Date2013Placesan deigo
Genetic variants in OPG and ANKH are associated with severity of ankylosis in ankylosing spondylitis in a Korean cohort

김태환

ConferenceIssue Date2013Placesan diego
Genetic Variants In OPG and ANKH Are Associated With Severity Of ankylosis In Ankylosing Spondylitis In a Korean Cohort.

방소영

ConferenceIssue Date2013PlaceSan Diego
Targeted exon resequencing for Korean RA

이혜순

ConferenceIssue Date2013PlaceSan Diego, CA, USA
Efficacy and safety of CT-P13(infliximab biosimilar) over two years in patients with rheumatoid arthritis: comparison between continued CT-P`13 and switching from infliximab to CT-P13

유대현

ConferenceIssue Date2013PlaceSan Diego, CA, USA
Targeted Exon Resequencing For Korean Rheumatoid Arthritis.

방소영

ConferenceIssue Date2013PlaceSan Diego
Impact of CT-P13 and originator infliximab treatment on quality of life derived from the health assrssment questionnaire(HAQ) and a short form 36(SF36) from a randomized double blinded trial in patients with active RA

유대현

ConferenceIssue Date2013PlaceSan Diego, CA, USA
Targeted exon resequencing for Korean rheumatoid arthritis

유대현

ConferenceIssue Date2013PlaceSan Diego, CA, USA
Is isoniazid treatment for LTBI safe for RA patients with TNF inhibitor therapy

유대현

ConferenceIssue Date2013PlaceSan Diego, USA
Efficacy and Safety of CT-P13 (Infliximab Biosimilar) over Two Years in Patients with Ankylosing Spondylitis: Comparison Between Continuing with CT-P13 and Switching from Infliximab to CT-P13

유대현

ConferenceIssue Date2013PlaceSan Diego
Is Isoniazid Treatment For LTBI Safe For RA Patients With TNF Inhibitor Therapy?

전재범

ConferenceIssue Date2013PlaceSan Diego, CA, USA
Targeted Exon Resequencing For Korean Rheumatoid Arthritis

전재범

ConferenceIssue Date2013PlaceSan Diego, CA, USA
Tomosynthesis As a New Diagnostic Tool For Evaluation Of Ankylosing Spondylitis With Modified Stoke Ankylosing Spondylitis Spinal Score: A Comparison With Plain Radiographs

전재범

ConferenceIssue Date2013PlaceSan Diego, CA, USA
Follow up testing of interferon-gamma release assays for the diagnosis of hidden tuberculosis infection in patients receiving tumor necrosis factor alpha antagonists

유대현

ConferenceIssue Date2013PlaceSan Diego, USA
Follow-Up Testing Of Interferon-Gamma Release Assays For The Diagnosis Of Hidden Tuberculosis Infection In Patients Receiving Tumor Necrosis Factor Alpha Antagonists

전재범

ConferenceIssue Date2013PlaceSan Diego, CA, USA
Calcium pyrophospahate dihydrate deposition disease SSOXIATED WITH PRIMARY HYPERPARATHYROIDDISM

김동선

ConferenceIssue Date2013Place부산
Efficacy and compliance of low carbohydrate diet education on nonalcoholic fatty liver disease in Korea

전대원

ConferenceIssue Date2013Place워싱턴 DC
Slower cortical auditory processing in patients with liver cirrhosis without clinical symptoms of hepatic encephalopathy

전대원

ConferenceIssue Date2013Place워싱턴 DC
first 251 252 253 254 255 256 257 258 259 260 last

Discover

Type

Language

CONTACT US

RSS_1.0 RSS_2.0 ATOM_1.0

222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366

COPYRIGHT © 2024 HANYANG UNIVERSITY.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어